KR20250065702A - 피부외용제 조성물 - Google Patents

피부외용제 조성물 Download PDF

Info

Publication number
KR20250065702A
KR20250065702A KR1020257011978A KR20257011978A KR20250065702A KR 20250065702 A KR20250065702 A KR 20250065702A KR 1020257011978 A KR1020257011978 A KR 1020257011978A KR 20257011978 A KR20257011978 A KR 20257011978A KR 20250065702 A KR20250065702 A KR 20250065702A
Authority
KR
South Korea
Prior art keywords
mass
component
composition
skin
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020257011978A
Other languages
English (en)
Korean (ko)
Inventor
다이스케 나카노
이사오 하타케야마
카즈요시 요코타
Original Assignee
제리아 신야쿠 고교 가부시키 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제리아 신야쿠 고교 가부시키 가이샤 filed Critical 제리아 신야쿠 고교 가부시키 가이샤
Publication of KR20250065702A publication Critical patent/KR20250065702A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
KR1020257011978A 2022-09-13 2023-09-13 피부외용제 조성물 Pending KR20250065702A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2022-145110 2022-09-13
JP2022145110 2022-09-13
PCT/JP2023/033283 WO2024058193A1 (ja) 2022-09-13 2023-09-13 皮膚外用剤組成物

Publications (1)

Publication Number Publication Date
KR20250065702A true KR20250065702A (ko) 2025-05-13

Family

ID=90275130

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020257011978A Pending KR20250065702A (ko) 2022-09-13 2023-09-13 피부외용제 조성물

Country Status (5)

Country Link
JP (1) JPWO2024058193A1 (enrdf_load_stackoverflow)
KR (1) KR20250065702A (enrdf_load_stackoverflow)
CN (1) CN119894520A (enrdf_load_stackoverflow)
TW (1) TW202417003A (enrdf_load_stackoverflow)
WO (1) WO2024058193A1 (enrdf_load_stackoverflow)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5742621A (en) 1980-08-29 1982-03-10 Zenyaku Kogyo Kk Composition for oryzanol external pharmaceutical
JP2004308530A (ja) 2003-04-04 2004-11-04 Calsonic Compressor Seizo Kk 気体圧縮機
JP2005178748A (ja) 2003-12-19 2005-07-07 Dr Ing H C F Porsche Ag 車両底部に取付可能なフットレスト
JP2008231087A (ja) 2007-02-22 2008-10-02 Kose Corp 皮膚外用剤
JP2016188187A (ja) 2015-03-30 2016-11-04 株式会社池田模範堂 外用医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6265624B2 (ja) * 2012-05-11 2018-01-24 ロート製薬株式会社 ルリコナゾール含有外用医薬組成物
JP6920031B2 (ja) * 2016-06-30 2021-08-18 小林製薬株式会社 慢性角化型湿疹改善剤
JP7313111B2 (ja) * 2017-06-06 2023-07-24 小林製薬株式会社 皮脂分泌促進剤及び外用組成物

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5742621A (en) 1980-08-29 1982-03-10 Zenyaku Kogyo Kk Composition for oryzanol external pharmaceutical
JP2004308530A (ja) 2003-04-04 2004-11-04 Calsonic Compressor Seizo Kk 気体圧縮機
JP2005178748A (ja) 2003-12-19 2005-07-07 Dr Ing H C F Porsche Ag 車両底部に取付可能なフットレスト
JP2008231087A (ja) 2007-02-22 2008-10-02 Kose Corp 皮膚外用剤
JP2016188187A (ja) 2015-03-30 2016-11-04 株式会社池田模範堂 外用医薬組成物

Also Published As

Publication number Publication date
WO2024058193A1 (ja) 2024-03-21
CN119894520A (zh) 2025-04-25
JPWO2024058193A1 (enrdf_load_stackoverflow) 2024-03-21
TW202417003A (zh) 2024-05-01

Similar Documents

Publication Publication Date Title
US20230338275A1 (en) Method and Formulation for Improving Roflumilast Skin Penetration Lag Time
TWI240635B (en) Active vitamin D3 emulsion lotion
AU2021268977B2 (en) Treatment of skin conditions using high Krafft temperature anionic surfactants
WO2012011566A1 (ja) タクロリムスを含有する水中油型クリーム状組成物
JP3731607B2 (ja) コルチコステロイドを含む油中水型ローション
JP2018197202A (ja) 乳化組成物
TWI806867B (zh) 乳化組成物
JP2003212716A (ja) 液晶型乳化組成物
JP7606104B2 (ja) 外用剤組成物
JPWO2020138000A1 (ja) 液晶乳化組成物、及びその製造方法
TW202228713A (zh) 外用乳化組成物
KR20250065702A (ko) 피부외용제 조성물
JP5912238B2 (ja) 乳化組成物
JP7398211B2 (ja) 外用組成物
JP7712737B1 (ja) オキサゾール化合物含有組成物
JP4521899B2 (ja) クロタミトン含有皮膚外用液剤
JP7642361B2 (ja) 外用医薬組成物
JP2025095431A (ja) 外用組成物
JP2023090338A (ja) 乳化組成物
WO2022131079A1 (ja) 外用組成物
JP2014172904A (ja) 酪酸クロベタゾンを含有するアトピー性皮膚炎用の外用医薬組成物
JP5674786B2 (ja) タクロリムスを含有する水中油型クリーム状組成物
CA3163637A1 (en) Topical pharmaceutical formulation
WO2008038806A1 (fr) Agent antipruritique
JP2015199730A (ja) 皮膚外用剤の使用性の評価法及び該評価法で使用性に優れると判別される皮膚外用剤

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20250411

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application